Biotech Startups

IVIDATA Life Sciences is a French consulting firm serving healthcare and life sciences players, supporting projects from clinical research through market launch. Its roughly 140 consultants work across three areas: biometrics and data, clinical operations and development, and regulatory affairs and vigilance, with a European focus.

3 investors

IVIM Technology develops intravital microscopy systems, including confocal and two-photon microscopes for in vivo imaging of living organisms, and provides contract research organization (CRO) services for preclinical in vivo imaging. It serves academic and pharmaceutical researchers, with an R&D center in Daejeon.

3 investors

Jacobio is a biopharmaceutical company developing novel oncology therapeutics, focusing on next-generation antibody-conjugated drugs including ATDCs, ISACs, and AOCs to treat cancer patients.

3 investors

Jaguar Gene Therapy develops gene therapy treatments for severe genetic diseases, focusing on AAV-based platform therapies designed to deliver one-time, long-lasting treatments. The company serves patients with severe genetic diseases with significant unmet medical needs.

3 investors

Janux Therapeutics is a clinical-stage biotech company developing precision-engineered immunotherapies for the treatment of cancer and autoimmune diseases. It uses its TRACTr, TRACIr, and ARM platforms to engineer drug candidates intended to direct the immune system against disease while limiting systemic safety issues.

3 investors

JNPMEDI is a South Korean company that builds medical data platforms using blockchain and cloud technology, including a clinical trial data management solution. It serves clinical trial and healthcare clients, and in 2024 expanded into professional services applying digital technology across clients' business processes.

3 investors

Joywell Foods (Oobli) produces sweet proteins found in rare fruits and berries that taste like sugar but digest like protein, and can replace up to 90% of sugar in products such as beverages and baked goods. It supplies these ingredients to food companies as an alternative sweetener.

3 investors

Seattle-based cancer immunotherapy company developing CAR-T and TCR cell therapies; acquired by Celgene, now part of Bristol-Myers Squibb.

3 investors

A biopharmaceutical company developing CAR-T cell therapies for cancer treatment. The company produces Benastim (瑞基奥仑赛注射液), a CAR-T therapeutic approved by China's National Medical Products Administration.

3 investors

K18 develops biotechnology-based hair care products designed to repair and strengthen hair for consumers. The company's patented molecular technology targets hair damage across all hair types through both professional salon and at-home product lines.

3 investors

A biotechnology company developing cancer therapies for patients with unmet medical needs. Its clinical pipeline includes the KTX-1001 and KTX-2001 programs.

3 investors

Kaffe Bueno upcycles coffee by-products into functional ingredients for consumer and industrial applications, operating as a sustainable biotech company focused on circular economy principles.

3 investors

KAICO produces difficult-to-express proteins using silkworm technology for use as pharmaceuticals, diagnostic tools, and reagents. The company partners with pharmaceutical manufacturers to develop new drugs using its core platform for protein production in silkworms.

3 investors

KalVista Pharmaceuticals is a global biopharmaceutical company that develops oral therapies for rare diseases, starting with hereditary angioedema (HAE). Its pipeline includes preclinical oral Factor XIIa inhibitors targeting HAE prophylaxis as well as thrombosis and inflammation.

3 investors

Kardium develops the Globe Pulsed Field System, an all-in-one cardiac ablation catheter with 122 individually selectable electrodes that combines high-density mapping and pulsed field ablation. It is designed for physicians treating patients with atrial fibrillation.

3 investors

Karyopharm is a pharmaceutical company developing drugs based on its SINE (Selective Inhibitor of Nuclear Export) technology, with medicines targeting cancers including multiple myeloma and diffuse large B-cell lymphoma. It serves patients and healthcare providers in oncology.

3 investors

Katalyze builds AI agents and a Primary Production Record that unify process data across batches, sites, and instruments to surface the signals affecting yield and quality, returning each with supporting evidence for expert review. It targets industrial and biopharma/manufacturing production teams to improve commercial yield, plant throughput, and reduce deviation investigations.

3 investors

Kayo Therapeutics is a biotechnology company developing therapeutics, with a scientific and clinical focus that includes areas such as metabolic disease and oncology. The company is led by an experienced management team supported by scientific and clinical advisory boards.

3 investors

KBCols Sciences uses biotechnology to develop sustainable pigments and bioactive compounds for industrial applications across fashion, beauty, personal care, and food sectors by screening India's biodiversity.

3 investors

Kimia is a therapeutics company developing new drugs through its ATLAS platform, working with partners in the pharmaceutical and biotechnology industries. It focuses on improving outcomes for patients.

3 investors

3 investors

3 investors

Kira Pharmaceuticals is a biotech company developing therapies targeting complement biology to treat complement-mediated diseases. Its work combines drug development and protein engineering, supported by academic collaborators and a scientific advisory board in complement biology and immunology.

3 investors

KnipBio produces JUV, a fermented all-natural feed ingredient added to existing aquaculture feed to improve juvenile survival, stress resilience, and yields for farmed fish and shrimp. It serves aquaculture producers of species including shrimp, salmonids, and marine fishes, shipping its product worldwide.

3 investors